Curative Biotechnology Inc (CUBT)

[Gonzal]

Same as someone buying at 0.07 with 4 licenses versus someone buying at .70 after first IND filing.

We take a bigger risk at 0.07 without zero development.

The problem is you keep looking at this a a Share Price.

If you start looking at this as a company who over 2 years has assembled a strong experience team and has 4 licensed drug programs you will stop having panic attacks everyday.

Progress is visible from a company aspect. Simply re read all the previous PRs and put them on a timeline… progress. Only regrets here when the first IND is filed whether this year or next is that more shares were not added at 0.07.